news.cision.com

In 2016, Skånska Byggvaror will open five new stores in Sweden located in: Malmö, Örebro, Uppsala, Värmdö and Falun. The store openings will make it easier for home and house owners to access Skånska Byggvaror’s product range and, in parallel, contribute to the company’s omnichannel development.The investment in proprietary stores started in Stockholm and Gothenburg in 2014 and in Norrköping in 2015. Skånska Byggvaror is now expanding through the addition of five new stores. The first three stores will open in Malmö, Örebro and Uppsala and, thereafter, two stores will be opened, one in

Q4 and full year 2015 conference call invitation

MTG will publish its financial results for the fourth quarter and full year 2015 at 07:30 CET, on Wednesday February 3. MTG will hold a conference call at 09:00 CET the same day, hosted by Jørgen Madsen Lindemann, President and CEO, and Maria Redin, CFO.The conference call, which will be held in English, will begin with a short presentation of the report followed by a question-and-answer session. To participate, please dial: Sweden: +46(0)8 5065 3938UK: +44(0)20 3427 1914US: +1212 444 0481 The access pin code for the call is 1170425 To ensure that the conference call starts on

SciBase’s PMA application advances to evaluation phase at FDA

In December 2015 SciBase submitted its application for pre-market approval of its Nevisense device to the U.S. Food and Drug Administration (FDA). Scibase has now received confirmation that FDA considers that the application is complete and contains all necessary information to move on to the evaluation phase and start to review the application.The PMA is the FDA’s most rigorous process for approval of new medical devices for the US market and is required for most so-called class III devices. Class III devices are usually based on a new method that has not been approved by the FDA yet. Due

Caroline Berg new Board member of Nordstjernan AB

The Nomination Committee of Nordstjernan AB proposes that Caroline Berg be elected as a new member and Vice Chairman of the Board of Directors at the Annual General Meeting on May 11, 2016. Caroline Berg is Chairman of Axel Johnson AB and the Erik and Göran Ennerfelt Fund for International Studies for Young Swedes, Vice Chairman of Mekonomen Group and a Board member of AxFast, Axfood, Axstores and the Advisory Board of the Stockholm School of Economics. From 2006 to 2014, Caroline Berg served as Director of Human Development and Communication and was a member of the Group management at

Lindab International AB: Lindab's Building Systems receives order for new sports arena in Salekhard (Northern Russia)

Wed, Jan 20, 2016 08:55 CET

Lindab's Building Systems has received an order worth approximately 43 MSEK to deliver an Astron® building to the city of Salekhard, which is located on the Arctic Circle in Northern Russia. The new arena will consist of an ice rink with appr. 3.000 seats, training halls, tennis courts, three swimming pools and a universal gym. The new arena can also be used for cultural events and exhibitions. The complex consists of several Astron single-storey and multi-storey blocks with a total area of 28,880 m². The main building is an AT polygonal structure with a free span of 58.5 m. All roof

Q-FREE – TOLLING CONTRACT IN THE US – 45 MNOK

Trondheim, Norway 20 January 2016; Q-Free Open Roads has been awarded a tolling contract from TransCore, US, at a value of NOK 45 million.The contract is a part of the upgrade of the Central Florida Expressway Authority’s electronic toll collection system. The Q-Free scope comprises the Intrada Image Review system including the new back office solution. The delivery will be executed in 2016 and followed by a 7.5-year service agreement. -We are pleased to be a subcontractor to TransCore, one of the largest companies in the world providing Tolling and ITS solutions. The award is

Diamyd Medical plans first interim report from the study DIAGNODE-1 where the diabetes vaccine Diamyd® is administered directly into lymph nodes

Wed, Jan 20, 2016 08:32 CET

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced in its first quarterly report for the fiscal year 2015/2016 that a first six month interim report for DIAGNODE-1, a clinical pilot study where the diabetes vaccine Diamyd® is administered directly into the lymph node, is intended to be presented during the first quarter of 2016. The study is open labeled, meaning not placebo-controlled. Professor Johnny Ludvigsson, Linköping University, is principal investigator and sponsor of the study. The report also announced that pre-clinical testing is ongoing to produce

Addnode Group renews agreement with leading Swedish engineering consultancy company, worth SEK 31 million

STOCKHOLM, JANUARY 20, 2016 – Cad-Q, a subsidiary of Addnode Group, the leading supplier of model- and drawing related IT in the Nordics has both renewed and expanded the agreement with one of Sweden’s largest engineering consultancy companies. The three year agreement has a total order value of SEK 31 million.The engineering consulting company is engaged in development within the fields of energy, industry and infrastructure and has a presence in over 30 countries worldwide. The company has chosen to both extend and expand the agreement with one of Addnode Group’s subsidiaries, Cad-Q,

Noreco announces receipt of updated tax ruling in Denmark

Oslo, 20 January 2015: Norwegian Energy Company ASA (“Noreco”), announces having received an updated ruling from the Danish tax authorities. Reference is made to Noreco’s Q1 report, "Subsequent events", where Noreco reported that Danish authorities had formally challenged Noreco Oil Denmark A/S’s taxable income for 2011 related to the sale of the Syd Arne field. The worst case scenario would entail an additional payment of USD 10.5 million plus interest, but increasing corporate loss carry forward correspondingly. Noreco has challenged the reassessment and has now received an updated

Chile’s Largest Publisher Grupo Copesa Signs Contract with Cxense

Oslo, Norway – Cxense ASA (OSE: CXENSE) today announced an agreement with Grupo Copesa of Chile. The contract includes licensing of the Cxense DMP (Data Management Platform). Grupo Copesa is one of the largest media conglomerates in Chile. The group has several online newspapers and magazines and through their cross site ad network they control more than 300 million page views monthly. The group will use the Cxense DMP to create audience segments to increase advertising performance. Cxense DMP is becoming the leading Data Management Platform (DMP) for media companies, e-commerce sites,

Quarterly Report I 15/16

Wed, Jan 20, 2016 08:24 CET

September 2015 – November 2015Diamyd Medical AB (publ), Fiscal year 2015/2016Reporting period, September 1, 2015 – November 30, 2015 · Net result amounted to MSEK -4.3 (-5.9) · Net result per share amounted to SEK -0.2 (-0.3) · Cash flow from operating activities amounted to MSEK -4.8 (-5.8) · Liquid assets and short term investments amounted at the end of the period to MSEK 24.9 (29.8) Significant events after the reporting period · Preliminary 15-month results from DIABGAD, a 30-month pilot study with the diabetes vaccine Diamyd® in combination with vitamin D and

Women at higher risk to develop chronic obstructive pulmonary disease

A new study by researchers at Lund University, Sweden shows that women can have a considerably higher risk than men of developing Chronic Obstructive Pulmonary Disease (COPD).Using a new diagnostic method, researchers have now shown that the risk of developing Chronic Obstructive Pulmonary Disease can be twice as high for women as it is for men. This means that being a woman may be an independent risk factor for developing COPD. Johannes Luoto, a researcher at Lund University and a doctor at the geriatric clinic of Skåne University Hospital

Saniona and Upsher-Smith sign collaboration agreement for development of novel therapeutics for Neurological Disorders

Wed, Jan 20, 2016 08:23 CET

Saniona, a leading biotech company in the field of ion channels, and Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned UK subsidiary Proximagen Ltd., today announce that they have entered into a drug discovery and development collaboration. This collaboration will focus on research of new small molecule therapeutics for neurological disorders, using Saniona’s expertise in ion channels and related technology platforms. Under the terms of the agreement, Proximagen is granted exclusive worldwide rights to develop, manufacture and commercialise medicines identified through

Axactor signed a strategic contract with Santander Consumer Finance in Spain

Wed, Jan 20, 2016 08:15 CET

PRESS RELASE DATED 2016-01-20Axactor’s subsidiary ALD Abogados has signed a contract with Santander Consumer Finance in Spain for the legal collection area. The first volumes will be transferred to Axactor end of January, with a ramp up of number of claims during 2016, adding substantial new business. We are pleased to announce this strategic agreement with Santander Consumer Finance. This is an important milestone for Axactor/ALD in the Spanish market, and with the launch of the new collection center on Monday this week we are prepared to add additional new business volumes to our

Bondholders’ Meeting in Bong resolves on amendments to Convertible Bonds in order to enable the conversion into Bong shares.

The Bondholders’ Meeting held on 19 January 2016 resolved to amend the terms and conditions of the SEK 75 million Convertible Bonds 2013/2018 with ISIN SE0005281821 (the “Convertible Bonds”) in Bong AB (publ) ("Bong") as requested by Bong. The amendments are subject to approval by the EGM (defined below). Provided that such approval is granted, the amendments will enable Bong, as well as the Bondholders, to convert all Convertible Bonds into Bong shares at a conversion price of SEK 2.75 per share. In addition, the Bondholders shall during a three-month period be entitled to subscribe for in

Johannes Lind-Widestam steps down as CEO of Elos Medtech

Johannes Lind-Widestam has decided to vacate his position as President and Chief Executive Officer of Elos Medtech. He will remain in his current position during his period of notice and leave the company at midyear. The process of finding a successor for Johannes starts immediately. “We thank Johannes for the time he has worked as Chief Executive Officer of Elos Medtech,” says Stig-Arne Blom, Chairman of the Elos Medtech Board. “It is regrettable that he is leaving our group. Among his accomplishments, Johannes has contributed to the acquisition of our American subsidiary, Onyx Medical.

Invitation to Tobii’s conference call following the 2015 year-end report

Stockholm, January 20, 2016 – Tobii AB plans to publish the year-end report for the period January 1—December 30 on February 16 at 08.00 CET. Following this report Tobii will host a conference call with web cast presentation for investors, analysts and media.Tobii’s President and CEO Henrik Eskilsson and CFO Esben Olesen will present and comment on the report. After the presentation there will be time for questions. The presentation will be held in English. Time Tuesday, February 16, 2016 at 10:00 a.m. CET Dial in details Phone numbers for participants: SE +46 (0)8 50 65

Bravida starts collaboration with the Royal Institute of Technology to develop energy-smart solutions

Bravida sees an increasing demand for climate-friendly technical solutions and to contribute to a sustainable climate development. Through a collaboration with the Royal Institute of Technology (KTH) and by hiring Adnan Ploskić, PhD, who specialise in low temperature heating at the Division of Fluid and Climate Technology, Bravida takes the first step forward in that field.Efficient use of our natural resources is a challenge for our world. Through energy-efficient technological solutions that are installed and maintained correctly, Bravida contribute to a sustainable development. A major

Trading and operations update